Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in patients with breast cancer: a meta-analysis Min KaiyinTong LinglingJi Bin Review 24 August 2023 Pages: 1 - 9
Breast cancer and incidence of type 2 diabetes mellitus: a systematic review and meta-analysis Nanna JordtKasper Aalbæk KjærgaardDeirdre Cronin-Fenton Review Open access 01 September 2023 Pages: 11 - 22
Clinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database study Libo YangHeather LinYun Wu Preclinical study 11 August 2023 Pages: 23 - 32
Numerical and physical modeling of breast cancer based on image fusion and artificial intelligence Bartosz Dołęga-KozierowskiPiotr KasprzakMariusz Ptak Preclinical study Open access 25 July 2023 Pages: 33 - 43
Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case–control study Lin SuiYuqi YanDong Xu Preclinical study Open access 28 August 2023 Pages: 45 - 55
Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial Cristiano de Pádua SouzaAna Suellen Barroso CarneiroTomás Reinert Clinical Trial Open access 14 August 2023 Pages: 57 - 65
Association between 21-gene-assay and detection of disseminated tumor cells in patients with early breast cancer: results from the IRMA trial Léa L. VolmerDominik DannehlAndreas D. Hartkopf Clinical trial Open access 09 August 2023 Pages: 67 - 72
Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer Matthew G. DaveyRay AbbasMichael J. Kerin Clinical trial Open access 04 August 2023 Pages: 73 - 81
CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis Roya BehrouziAnne C. ArmstrongSacha J. Howell Clinical trial Open access 16 August 2023 Pages: 83 - 95
High neuroticism is associated with common late adverse effects in a nationwide sample of long-term breast cancer survivors Alv A. DahlSolveig K. SmedslandKristin V. Reinertsen Clinical trial Open access 01 August 2023 Pages: 97 - 104
COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019–2021 Judith A. MalmgrenBoya GuoHenry G. Kaplan Epidemiology Open access 16 August 2023 Pages: 105 - 115
Increases in BMI contribute to worsening inflammatory biomarkers related to breast cancer risk in women: a longitudinal study Yu HaoJinyu XiaoJiayuan Li Epidemiology 05 August 2023 Pages: 117 - 127
The impact of nurse navigation on timeliness to treatment for benign high-risk breast pathology Catherine S. BarkerCatherine W. ChungAndrea M. Abbott Epidemiology 16 August 2023 Pages: 129 - 137
Effect of neighborhood deprivation index on breast cancer survival in the United States Arya Mariam RoyAnthony GeorgeShipra Gandhi Epidemiology Open access 05 August 2023 Pages: 139 - 153
Factors associated with insomnia symptoms over three years among premenopausal women with breast cancer Chloe M. Beverly HerySarah A. JanseMichelle J. Naughton Epidemiology Open access 05 August 2023 Pages: 155 - 165
Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022 Niklas GremkeUwe WagnerKarel Kostev Brief Communication Open access 31 July 2023 Pages: 167 - 172
Combining the tumor-stroma ratio with tumor-infiltrating lymphocytes improves the prediction of pathological complete response in breast cancer patients Fengling LiHong ChenHong Bu Original Laboratory Investigation 01 August 2023 Pages: 173 - 183
Ipsilateral tumor recurrence risk in women with ductal carcinoma in situ: application of the Van Nuys Prognostic Index and the Memorial Sloan Kettering Cancer Center nomogram Kimberlee A. HashibaManisha Bahl Original Laboratory Investigation 30 July 2023 Pages: 185 - 190
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes Lauren LenzChris NeffKirsten M. Timms Original Laboratory Investigation Open access 17 August 2023 Pages: 191 - 201
Effects of neighborhood disadvantage on cortisol and interviewer-rated anxiety symptoms in breast cancer patients initiating treatment Neha GoelAlexandra E HernandezMichael H. Antoni Original Laboratory Investigation 10 August 2023 Pages: 203 - 211
Retraction Note: Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways C. BuchananI. StiglianoM. G. Peters Retraction Note 04 September 2023 Pages: 213 - 213
